HIV-1 Subtype Diversity Based on Envelope C2V3 Sequences from Kenyan Patients on Highly Active Antiretroviral Therapy

被引:0
|
作者
Kitawi, Rose C. [1 ,2 ]
Nzomo, Timothy [1 ,2 ]
Mwatelah, Ruth S. [1 ,2 ]
Aman, Rashid [1 ,3 ]
Kimulwo, Maureen J. [1 ,2 ]
Masankwa, Geoffrey [1 ,3 ]
Lwembe, Raphael M. [4 ]
Okendo, Javan [5 ]
Ogutu, Bernhards [1 ,4 ]
Ochieng, Washingtone [1 ,4 ,6 ]
机构
[1] Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya
[2] Inst Trop Med & Infect Dis, Nairobi, Kenya
[3] African Ctr Clin Trials, Nairobi, Kenya
[4] Kenya Govt Med Res Ctr, Nairobi, Kenya
[5] Kenyatta Univ, Nairobi, Kenya
[6] Harvard Univ, Sch Publ Hlth, Immunol & Infect Dis Dept, Boston, MA 02115 USA
基金
英国惠康基金;
关键词
GENETIC DIVERSITY; TYPE-1; SUBTYPES;
D O I
10.1089/aid.2014.0306
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is a continuous need to genetically characterize the HIV strains in circulation in order to assess interventions and inform vaccine discovery. We partially sequenced the envelope C2V3 gene from a total of 59 Kenyan patients on highly active antiretroviral treatment (HAART) and determined HIV subtypes using both the JPHMM subtyping tool and the phylogenetic method. HIV-1 subtype A1 was the predominant strain in circulation, representing 65.5% and 74.5% of all isolates as determined by JPHMM and phylogenetic methods, respectively. Subtypes C and D were the next most prevalent pure strains at 9.1% each by both methods. JPHMM identified 9.1% of the isolates as recombinant. Four isolates had short sequences not covering the entire C2V3 region and were thus not subtyped. From this study, subtype A viruses are still the predominant HIV-1 strains in local circulation in Kenya. Constant surveillance is needed to update molecular trends under continuing HAART scale-up.
引用
收藏
页码:452 / 455
页数:4
相关论文
共 50 条
  • [1] Inferior virological responses to highly active antiretroviral therapy in patients with HIV-1 subtype C infection: a case controlled study
    Loveday, C
    van Hooff, F
    Johnson, M
    [J]. ANTIVIRAL THERAPY, 2002, 7 : S189 - S189
  • [2] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
    Finzi, D
    Hermankova, M
    Pierson, T
    Carruth, LM
    Buck, C
    Chaisson, RE
    Quinn, TC
    Chadwick, K
    Margolick, J
    Brookmeyer, R
    Gallant, J
    Markowitz, M
    Ho, DD
    Richman, DD
    Siliciano, RF
    [J]. SCIENCE, 1997, 278 (5341) : 1295 - 1300
  • [3] Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
    Geretti, Anna Maria
    Harrison, Linda
    Green, Hannah
    Sabin, Caroline
    Hill, Teresa
    Fearnhill, Esther
    Pillay, Deenan
    Dunn, David
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (09) : 1296 - 1305
  • [4] Antibody reactivity to HIV-1 Vpu in HIV-1/AIDS patients on highly active antiretroviral therapy
    Chen, YMA
    Rey, WY
    Can, YC
    Lai, SF
    Huang, YC
    Wu, SI
    Liu, TT
    Hsiao, KJ
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2003, 10 (02) : 266 - 275
  • [5] Characterization of HIV-1 Envelope V3 Region Sequences from Virologically Controlled HIV-Infected Older Patients on Long Term Antiretroviral Therapy
    Behrens, Nicole E.
    Love, Maria
    Bandlamuri, Meghana
    Bernhardt, Dana
    Wertheimer, Anne
    Klotz, Stephen A.
    Ahmad, Nafees
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (03) : 233 - 245
  • [6] Viral tropism and antiretroviral drug resistance in HIV-1 subtype C infected patients initiating or failing highly active antiretroviral therapy in Johannesburg, South Africa
    Ketseoglou, I.
    Lukhwareni, A.
    Steegen, K.
    Carmona, S.
    Stevens, W. S.
    Papathanasopoulos, M. A.
    [J]. ANTIVIRAL THERAPY, 2013, 18 : A81 - A81
  • [7] Viral Tropism and Antiretroviral Drug Resistance in HIV-1 Subtype C-Infected Patients Failing Highly Active Antiretroviral Therapy in Johannesburg, South Africa
    Ketseoglou, Irene
    Lukhwareni, Azwidowi
    Steegen, Kim
    Carmona, Sergio
    Stevens, Wendy S.
    Papathanasopoulos, Maria A.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (03) : 289 - 293
  • [8] Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART
    Kitawi, Rose C.
    Hunja, Carol W.
    Aman, Rashid
    Ogutu, Bernhards R.
    Muigai, Anne W. T.
    Kokwaro, Gilbert O.
    Ochieng, Washingtone
    [J]. VIROLOGY JOURNAL, 2017, 14
  • [9] Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART
    Rose C. Kitawi
    Carol W. Hunja
    Rashid Aman
    Bernhards R. Ogutu
    Anne W. T. Muigai
    Gilbert O. Kokwaro
    Washingtone Ochieng
    [J]. Virology Journal, 14
  • [10] Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy
    Ye, P
    Kourtis, AP
    Kirschner, DE
    [J]. CLINICAL IMMUNOLOGY, 2003, 106 (02) : 95 - 105